GENNARI, LUIGI
 Distribuzione geografica
Continente #
NA - Nord America 8.588
EU - Europa 6.427
AS - Asia 1.186
SA - Sud America 20
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 10
AF - Africa 3
Totale 16.245
Nazione #
US - Stati Uniti d'America 8.562
GB - Regno Unito 1.542
IE - Irlanda 1.523
CN - Cina 973
UA - Ucraina 871
IT - Italia 658
SE - Svezia 647
FR - Francia 456
DE - Germania 369
FI - Finlandia 239
VN - Vietnam 77
TR - Turchia 68
ES - Italia 26
BE - Belgio 23
CA - Canada 21
RU - Federazione Russa 15
IN - India 14
EU - Europa 11
NL - Olanda 10
DK - Danimarca 9
BR - Brasile 8
IR - Iran 8
CL - Cile 7
HK - Hong Kong 7
AU - Australia 6
PL - Polonia 6
SG - Singapore 5
SY - Repubblica araba siriana 5
HU - Ungheria 4
IM - Isola di Man 4
MX - Messico 4
NZ - Nuova Zelanda 4
SA - Arabia Saudita 4
CH - Svizzera 3
GR - Grecia 3
JP - Giappone 3
NP - Nepal 3
PE - Perù 3
RO - Romania 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
AR - Argentina 2
AT - Austria 2
BD - Bangladesh 2
CZ - Repubblica Ceca 2
HR - Croazia 2
LV - Lettonia 2
PK - Pakistan 2
PT - Portogallo 2
RS - Serbia 2
ZA - Sudafrica 2
AZ - Azerbaigian 1
BG - Bulgaria 1
GE - Georgia 1
IL - Israele 1
IQ - Iraq 1
IS - Islanda 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MA - Marocco 1
MN - Mongolia 1
MY - Malesia 1
NO - Norvegia 1
PA - Panama 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 16.245
Città #
Dublin 1.506
Fairfield 1.499
Southend 1.400
Chandler 712
Jacksonville 708
Ashburn 695
Woodbridge 664
Wilmington 568
Houston 545
Cambridge 530
Seattle 528
Princeton 318
Ann Arbor 307
Nanjing 210
Siena 203
Beijing 186
Boardman 99
San Diego 94
Helsinki 91
Nanchang 83
Shanghai 77
Dong Ket 72
Izmir 65
San Mateo 62
Shenyang 56
Dearborn 47
Florence 45
London 44
Tianjin 44
Hebei 41
Jiaxing 37
Kunming 35
Changsha 28
Milan 25
Redwood City 24
Rome 23
Málaga 22
Norwalk 22
Brussels 21
Falls Church 18
Jinan 18
New York 18
Fremont 16
Zhengzhou 16
Hangzhou 15
Menlo Park 15
San Francisco 15
Venezia 15
Düsseldorf 14
Ningbo 12
Lanzhou 11
Toronto 11
Lappeenranta 10
Los Angeles 10
Kilburn 9
Chiswick 8
Guangzhou 8
Prato 8
Taizhou 8
Tappahannock 8
Washington 8
Fuzhou 7
Saronno 7
Aachen 6
Chicago 6
Codogno 6
Palermo 6
Philadelphia 6
Verrua Po 6
Zanjan 6
Da Nang 5
Islington 5
Lancaster 5
Naples 5
New Bedfont 5
Phoenix 5
Bologna 4
Bonndorf 4
Budapest 4
Changchun 4
Hefei 4
Hong Kong 4
Paris 4
Renton 4
Riyadh 4
Scandicci 4
Sevilla 4
Voghera 4
Warsaw 4
Yellow Springs 4
Acton 3
Arezzo 3
Belvedere Marittimo 3
Canberra 3
Casalnuovo di Napoli 3
Copenhagen 3
Edinburgh 3
Indiana 3
Kathmandu 3
Lamezia Terme 3
Totale 12.179
Nome #
null 398
Activation of the Wnt pathway by small peptides: rational design, synthesis and biological evaluation 184
Falls, fractures and vitamin D: a never-ending story? 177
ZNF687 Mutations in Severe Paget Disease of Bone Associated with Giant Cell Tumor 160
Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes 159
Endocrine actions of osteocalcin 146
SQSTM1 gene analysis and gene-environment interaction in Paget's disease of bone 144
Dual X-ray absorptiometry and bone ultrasonography in patients with Rett Syndrome 143
Evidence of a linkage disequilibrium between polymorphisms in the human estrogen receptor alpha gene and their relationship to bone mass variation in postmenopausal Italian women 142
The combined use of ultrasound and densitometry in the prediction of vertebral fracture 141
The impact of infarct size on regional and global left ventricular systolic function: a cardiac magnetic resonance imaging study 141
Undiagnosed vertebral fractures influence quality of life in postmenopausal women with reduced ultrasound parameters. 141
Characteristics and familial aggregation of Paget's disease of bone in Italy 140
The usefulness of quantitative ultrasound (QUS) measurements in the evaluation of skeletal status in newborns and in children 139
Common susceptibility alleles and SQSTM1 mutations predict disease extent and severity in a multinational study of patients with Paget's disease 137
Misdiagnosis of vertebral fractures on local radiographic readings of the multicentre POINT (Prevalence of Osteoporosis in INTernal medicine) study 137
Allelic variants of human calcitonin receptor: distribution and association with bone mass in postmenopausal Italian women 136
Vitamin D receptor genotypes and intestinal calcium absorption in postmenopausal women 135
Alendronate treatment in men with primary osteoporosis: a three-year longitudinal study 135
Comparison of intravenous and intramuscular neridronate regimens for the treatment of Paget disease of bone 133
The association of body composition and sexhormones with quantitative ultrasound parameters at the calcaneus and phalanxes in elderly women. 131
Longitudinal association between sex hormone levels, bone loss and bone turnover in elderly men. 129
Corretto uso dei marcatori del rimodellamento osseo 128
null 128
Vitamin D receptor gene polymorphisms predict acquired resistance to clodronate treatment in patients with Paget's disease of bone 125
A non-synonymous TNFRSF11A variation increases NFkB activity and the severity of Paget's disease 125
Paget disease of bone-associated UBA domain mutations of SQSTM1 exert distinct effects on protein structure and function 124
Serum OPG and RANKL levels before and after intravenous bisphosphonate treatment in Paget’s disease of bone 123
Prevalence of Paget’s disease of bone in Italy 123
Prevalence of Helicobacter pylori infection in male patients with osteoporosis and controls 122
null 122
Aromatase activity and bone homeostasis in men 121
Left ventricular hypertrophy differences in male professional runners and in young patients suffering from mild hypertension 121
Age-related decline of bone mass and intestinal calcium absorption in normal males 121
The use of intravenous aminobisphosphonates for the treatment of Paget's disease of bone 121
Osteoporosis in men: pathophysiology and treatment 120
Absence of correlation between BMP-4 polymorphism and postmenopausal osteoporosis in Italian women 119
The effects of recombinant TSH on bone turnover markers and serum osteoprotegerin and RANKL levels 119
Aromatase activity and bone loss 119
Effect of Electromagnetic Fields on Bone Mineral Density and Biochemical Markers of Bone Turnover in Osteoporosis: A single-Blind, Randomized Pilot Study 118
Bazedoxifene for the prevention of postmenopausal osteoporosis 117
Polymorphism of the aromatase gene in postmenopausal Italian women: distribution and correlation with bone mass and fracture risk 117
Idiopathic osteoporosis in men 117
Quantitative ultrasound and dual-energy X-ray absorptiometry in the prediction of fragility fracture in men 115
Aromatase activity and bone loss in men 115
Bona fide genetic associations with bone mineral density 115
The effects of zoledronic acid on serum lipids in multiple myeloma patients 114
Epidemiological, clinical, and genetic characteristics of Paget's disease of bone in a rural area of Calabria, Southern Italy 114
FokI polymorphism at translation initiation site of the vitamin D receptor gene predicts bone mineral density and vertebral fractures in postmenopausal Italian women 114
Bisphosphonates target B cells to enhance humoral immune responses 114
The relationship between plasma homocysteine levels and bone mineral density in post-menopausal women 114
Vitamin D and estrogen receptor allelic variants in Italian postmenopausal women: evidence of multiple gene contribution to bone mineral density 113
Polymorphisms of the calcitonin receptor gene are associated with bone mineral density in postmenopausal Italian women 113
Mild brachydactyly type A1 maps to chromosome 2q35-q36 and is caused by a novel IHH mutation in a three generation family 112
Paget's disease of bone: epidemiology, pathogenesis and pharmacotherapy 111
Lasofoxifene, from the preclinical drug discovery to the treatment of postmenopausal osteoporosis 111
Membrane binding sites and non-genomic effects of estrogen in cultured human pre-osteoclastic cells 110
Update on the pharmacogenetics of the vitamin D receptor and osteoporosis 110
Helicobacter pylori seroprevalence in patients with idiopathic pulmonary fibrosis 110
Pharmacokinetic evaluation of toremifene and its clinical implications for the treatment of osteoporosis 110
Comparison of different intravenous bisphosphonate regimens for Paget's disease of bone. 109
Osteoporosis in men: pathophysiology and treatment 109
FSHR gene polymorphisms influence bone mineral density and bone turnover in postmenopausal women 107
Genetics of osteoporosis: role of steroid hormone receptor gene polymorphisms 107
Perspectives in the treatment and prevention of osteoporosis 106
Usefulness of bone quantitative ultrasound in management of osteoporosis in men 106
Telomerase repeat amplification protocol (TRAP): A new molecular marker for parathyroid carcinoma 106
Selective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifene 105
Mechanisms of impaired bone strength in type 1 and 2 diabetes 105
PTH in the pathogenesis and treatment of glucocorticoid-induced osteoporosis 105
null 105
Quantitative ultrasound and bone mineral density in patients with primary hyperparathyroidism before and after surgical treatment 104
Effect of electromagnetic fields on bone mineral density and biochemical markers of bone turnover in osteoporosis: a single-blind, randomized, pilot study 104
Feasibility of quantitative ultrasound measurements on the humerus of newborn infants for the assessment of the skeletal status. 103
Giant cell tumor occurring in familial Paget's disease of bone: report of clinical characteristics and linkage analysis of a large pedigree 103
Effect of electromagnetic fields on bone mineral density and biochemical markers of bone turnover in osteoporosis: a single-blind, randomized pilot study 103
null 103
Ospemifene use in postmenopausal women 102
Lasofoxifene: Evidence of its therapeutic value in osteoporosis 102
A polymorphic CYP19 TTTA repeat influences aromatase activity and estrogen levels in elderly men: effects on bone metabolism. 99
Evidence for increased clinical severity of familial and sporadic Paget’s disease of bone in Campania, southern Italy 98
Estrogen and fracture risk in men 98
Heel ultrasonography in monitoring alendronate therapy: a four-year longitudinal study 98
Steroid hormone receptor gene polymorphisms and osteoporosis: a pharmacogenomic review 98
Association of the estrogen receptor alpha gene polymorphisms with sporadic Alzheimer's disease 98
Does calcium supplementation reduce the risk of osteoporotic fracture and bone loss? 97
Paget’s disease of bone in Italy. 97
Treatment of post-menopausal osteoporosis with recombinant human growth hormone and salmon calcitonin: a placebo controlled study 97
Relation of plasma brain natriuretic peptide levels in non-ST-elevation coronary disease and preserved systolic function to number of narrowed coronary arteries 96
Lasofoxifene: selective estrogen receptor modulator for the prevention and treatment of postmenopausal osteoporosis 96
Lasofoxifene: a third-generation selective estrogen receptor modulator for the prevention and treatment of osteoporosis 94
Left ventricular diastolic function improvement by carvedilol therapy in advanced heart failure 94
Lasofoxifene: a new-generation SERM for the treatment of postmenopausal osteoporosis 94
Raloxifene in breast cancer prevention 93
Association of polymorphisms of the estrogen receptor alpha gene with bone mineral density and fracture risk in women: a meta-analysis 93
Mutation of PFN1 Gene in an Early Onset, Polyostotic Paget-like Disease 93
Lasofoxifene, a new selective estrogen receptor modulator for the treatment of osteoporosis and vaginal atrophy 91
Glucocorticoid-induced osteoporosis: hope on the HORIZON 91
null 90
Genetics of male osteoporosis 89
Totale 11.881
Categoria #
all - tutte 55.408
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.408


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.036 0 0 0 0 0 0 0 0 0 0 558 478
2019/20203.941 470 126 249 624 240 284 303 502 319 415 144 265
2020/20212.677 129 330 92 266 93 311 99 484 267 173 222 211
2021/20221.957 125 280 85 203 69 57 87 69 126 228 178 450
2022/20232.698 185 176 358 391 293 588 55 201 271 47 95 38
2023/20242.057 230 77 218 73 54 536 745 45 18 59 2 0
Totale 16.562